000022891 001__ 22891
000022891 005__ 20180210125445.0
000022891 037__ $$aPreJuSER-22891
000022891 1001_ $$0P:(DE-Juel1)138474$$aMatusch, A.$$b0$$uFZJ
000022891 1112_ $$cStockholm, Schweden$$d2012-09-14
000022891 245__ $$aSwitch of cerebral A1 adenosine receptor radioligand binding during phenoconversion of Huntington's disease - a PET study
000022891 260__ $$c2012
000022891 29510 $$aEHDN 2012
000022891 3367_ $$0PUB:(DE-HGF)24$$2PUB:(DE-HGF)$$aPoster
000022891 3367_ $$033$$2EndNote$$aConference Paper
000022891 3367_ $$2DataCite$$aOutput Types/Conference Poster
000022891 3367_ $$2DRIVER$$aconferenceObject
000022891 3367_ $$2ORCID$$aCONFERENCE_POSTER
000022891 3367_ $$2BibTeX$$aINPROCEEDINGS
000022891 500__ $$aRecord converted from VDB: 12.11.2012
000022891 536__ $$0G:(DE-Juel1)FUEK409$$2G:(DE-HGF)$$aFunktion und Dysfunktion des Nervensystems$$cP33$$x0
000022891 7001_ $$0P:(DE-HGF)0$$aSaft, C.$$b1
000022891 7001_ $$0P:(DE-Juel1)131679$$aElmenhorst, D.$$b2$$uFZJ
000022891 7001_ $$0P:(DE-HGF)0$$aKraus, P.H.$$b3
000022891 7001_ $$0P:(DE-HGF)0$$aGold, R.$$b4
000022891 7001_ $$0P:(DE-HGF)0$$aHartung, H.-P.$$b5
000022891 7001_ $$0P:(DE-Juel1)131672$$aBauer, A.$$b6$$uFZJ
000022891 909CO $$ooai:juser.fz-juelich.de:22891$$pVDB
000022891 9131_ $$0G:(DE-Juel1)FUEK409$$1G:(DE-HGF)POF2-330$$2G:(DE-HGF)POF2-300$$bGesundheit$$kP33$$lFunktion und Dysfunktion des Nervensystems$$vFunktion und Dysfunktion des Nervensystems$$x0
000022891 9141_ $$y2012
000022891 9201_ $$0I:(DE-Juel1)INM-2-20090406$$gINM$$kINM-2$$lMolekulare Organisation des Gehirns$$x0
000022891 970__ $$aVDB:(DE-Juel1)139687
000022891 980__ $$aVDB
000022891 980__ $$aConvertedRecord
000022891 980__ $$aposter
000022891 980__ $$aI:(DE-Juel1)INM-2-20090406
000022891 980__ $$aUNRESTRICTED